We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Patient group direction (PGD) template to support the provision of hepatitis B vaccine to renal patients.
Information for health professionals on vaccine ordering and storage.
An explanation of the key performance indicators (KPIs) for NHS population screening in England.
These documents list sickle cell and thalassaemia high and low prevalence NHS Trusts in England and explain how prevalence is determined.
Resources to support the management of children who missed newborn screening tests.
Information for public health professionals on immunisation.
A guide and set of resources to support local authorities with implementing a whole systems approach to address obesity and promote a healthy weight.
Guidelines covering primary HPV and primary cytology screening pathways, to avoid and manage errors (or missed screens) during the cervical screening process.
Data to support providers in improving cervical screening coverage and access to cervical screening services.
E-learning modules for healthcare professionals on minimising the risks of using medicines and information on how to access medical device modules.
These documents describe the fetal anomaly screening programme (FASP) pathways.
Patient group direction (PGD) template to support the provision of HPV vaccine to gay, bisexual, and men who have sex with men (GBMSM).
How to use a randomised controlled trial to evaluate your digital health product.
Requirements for the quality assurance of laboratories providing antenatal and newborn screening services by the United Kingdom Accreditation Service (UKAS).
These documents support screening quality assurance (QA), and screening providers carrying out annual 'Right Results' audits in breast screening.
Guidance on naming human medicines, including Braille requirements for the name on the product label.
Letter and directions setting out general ophthalmic services fees, payments, optical voucher values and hospital eye service charges from 1 April 2024.
How to use a clinical audit to evaluate your digital health product.
This document explains the quality assurance support service for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome screening (DQASS).
The mycology reference laboratory (MRL) provides a comprehensive laboratory service for the diagnosis and management of fungal infections.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).